相关实验视频
Updated: Jul 24, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
关于深度大脑刺激对帕金森病驾驶的影响的前性对照研究
Odette Fründt1,2, Tina Mainka1,3,4, Eik Vettorazzi5
1Department of Neurology, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
NPJ Parkinson's disease
|July 2, 2023
概括
在帕金森氏症患者中,双边脑下深层刺激 (STN-DBS)
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 显著影响运动和非运动功能,可能会影响驾驶能力.
- 深度大脑刺激 (DBS) 是高级PD的常见治疗方法,但其对驾驶安全的影响尚未完全理解.
- 脑下细胞核 (STN) DBS是PD管理中经常使用的手术干预.
研究的目的:
- 预期评估双边STN-DBS对PD患者汽车驾驶表现的影响.
- 为了比较经过STN-DBS的PD患者和那些符合条件但没有手术的PD患者的驾驶安全性.
- 为了确定与STN-DBS后驾驶能力的变化相关的因素.
主要方法:
- 前性研究比较了两组主动驾驶PD患者:STN-DBS (n=23) 和非DBS (n=29).
- 在STN-DBS组的基线 (手术前) 和手术后6-12个月评估的驾驶能力.
- 在基线时,驾驶表现在不同组和健康对照组 (n=33) 之间进行了比较.
主要成果:
- 在基线时,PD-DBS,PD-nDBS和对照组之间的临床或驾驶特征没有显著差异.
- 在随访时,PD-DBS患者的驾驶表现略有下降,主要是由于两个异常值与先前存在的驾驶不安全性.
- 除了异常值外,在随访时,PD-DBS和PD-nDBS组之间的驾驶表现仍然可比. 年龄,疾病持续时间/严重程度和基线驾驶不安全性预测后续效果较差.
结论:
- 双边STN-DBS通常不会对帕金森病患者的驾驶安全产生负面影响.
- 一小部分接受STN-DBS治疗的PD患者可能会出现驾驶恶化的风险增加,特别是那些事先有驾驶不安全感的人.
- 需要进一步的研究,以确定STN-DBS后驱动性恶化的预测因素.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
302
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
302
Parkinson's Disease: Overview
606
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
606

